238 related articles for article (PubMed ID: 17102549)
1. Malaria: anti malarial resistance and policy ramifications and challenges.
Kshirsagar NA
J Postgrad Med; 2006; 52(4):291-3. PubMed ID: 17102549
[TBL] [Abstract][Full Text] [Related]
2. Parasitological and clinical efficacy of standard treatment regimens against Plasmodium falciparum, P. vivax and P. malariae in Papua New Guinea.
Genton B; Baea K; Lorry K; Ginny M; Wines B; Alpers MP
P N G Med J; 2005; 48(3-4):141-50. PubMed ID: 17212060
[TBL] [Abstract][Full Text] [Related]
3. Low efficacy of amodiaquine or chloroquine plus sulfadoxine-pyrimethamine against Plasmodium falciparum and P. vivax malaria in Papua New Guinea.
Marfurt J; Müeller I; Sie A; Maku P; Goroti M; Reeder JC; Beck HP; Genton B
Am J Trop Med Hyg; 2007 Nov; 77(5):947-54. PubMed ID: 17984359
[TBL] [Abstract][Full Text] [Related]
4. Malaria treatment in Vanuatu: new national treatment guidelines.
Reeve PA
P N G Med J; 1994 Sep; 37(3):181-8. PubMed ID: 7668057
[TBL] [Abstract][Full Text] [Related]
5. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
6. Randomized trial of 3-dose regimens of tafenoquine (WR238605) versus low-dose primaquine for preventing Plasmodium vivax malaria relapse.
Walsh DS; Wilairatana P; Tang DB; Heppner DG; Brewer TG; Krudsood S; Silachamroon U; Phumratanaprapin W; Siriyanonda D; Looareesuwan S
Clin Infect Dis; 2004 Oct; 39(8):1095-103. PubMed ID: 15486831
[TBL] [Abstract][Full Text] [Related]
7. Increased gametocytemia after treatment: an early parasitological indicator of emerging sulfadoxine-pyrimethamine resistance in falciparum malaria.
Barnes KI; Little F; Mabuza A; Mngomezulu N; Govere J; Durrheim D; Roper C; Watkins B; White NJ
J Infect Dis; 2008 Jun; 197(11):1605-13. PubMed ID: 18471066
[TBL] [Abstract][Full Text] [Related]
8. Gametocytocidal effect of primaquine in a chemotherapeutic malaria control trial in North Sumatra, Indonesia.
Kaneko A; Kamei K; Suzuki T; Ishii A; Siagian R; Panjaitan W
Southeast Asian J Trop Med Public Health; 1989 Sep; 20(3):351-9. PubMed ID: 2699082
[TBL] [Abstract][Full Text] [Related]
9. Withdrawing antimalarial drugs: impact on parasite resistance and implications for malaria treatment policies.
Laufer MK; Plowe CV
Drug Resist Updat; 2004; 7(4-5):279-88. PubMed ID: 15533765
[TBL] [Abstract][Full Text] [Related]
10. Management of malaria before and after introduction of a treatment protocol at the Eldoret District Hospital.
Nabiswa AK; Makokha JD; Godfrey RC; Lore W
East Afr Med J; 1994 Jan; 71(1):9-13. PubMed ID: 8055773
[TBL] [Abstract][Full Text] [Related]
11. Artemisinin-based combination therapy for uncomplicated malaria in sub-Saharan Africa: the efficacy, safety, resistance and policy implementation since Abuja 2000.
Ogbonna A; Uneke CJ
Trans R Soc Trop Med Hyg; 2008 Jul; 102(7):621-7. PubMed ID: 18499204
[TBL] [Abstract][Full Text] [Related]
12. Emergence of drug resistance in India.
Arora U; Sonal GS; Dhillon GP; Thakor HG
J Indian Med Assoc; 2008 Oct; 106(10):678-81, 683. PubMed ID: 19552104
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of three chloroquine-primaquine regimens for treatment of Plasmodium vivax malaria in Colombia.
Alvarez G; Piñeros JG; Tobón A; Ríos A; Maestre A; Blair S; Carmona-Fonseca J
Am J Trop Med Hyg; 2006 Oct; 75(4):605-9. PubMed ID: 17038680
[TBL] [Abstract][Full Text] [Related]
14. Anti-malarial drug formulations and novel delivery systems: a review.
Murambiwa P; Masola B; Govender T; Mukaratirwa S; Musabayane CT
Acta Trop; 2011 May; 118(2):71-9. PubMed ID: 21439929
[TBL] [Abstract][Full Text] [Related]
15. Towards a rational drug policy for malaria.
Sehgal PN
Health Millions; 1998; 24(4):27, 29. PubMed ID: 12349581
[TBL] [Abstract][Full Text] [Related]
16. Primaquine therapy for malaria.
Baird JK; Hoffman SL
Clin Infect Dis; 2004 Nov; 39(9):1336-45. PubMed ID: 15494911
[TBL] [Abstract][Full Text] [Related]
17. Sulfadoxine-pyrimethamine plus artesunate compared with chloroquine for the treatment of vivax malaria in areas co-endemic for Plasmodium falciparum and P. vivax: a randomised non-inferiority trial in eastern Afghanistan.
Kolaczinski K; Durrani N; Rahim S; Rowland M
Trans R Soc Trop Med Hyg; 2007 Nov; 101(11):1081-7. PubMed ID: 17707447
[TBL] [Abstract][Full Text] [Related]
18. Plasmodium vivax relapses after 5 days of primaquine treatment, in some industrial complexes of India.
Dua VK; Sharma VP
Ann Trop Med Parasitol; 2001 Oct; 95(7):655-9. PubMed ID: 11784418
[TBL] [Abstract][Full Text] [Related]
19. [Plasmodium vivax malaria in the Brazilian Amazon: some aspects of its epidemiology, clinical spectrum and naturally induced immune responses].
Daniel-Ribeiro CT; Lacerda MV; Oliveira-Ferreira J
Bull Soc Pathol Exot; 2008 Jun; 101(3):243-8. PubMed ID: 18683322
[TBL] [Abstract][Full Text] [Related]
20. Management of malaria: recent trends.
Mehta SR; Das S
J Commun Dis; 2006 Mar; 38(2):130-8. PubMed ID: 17370675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
